Phio Pharmaceuticals Statistics
Total Valuation
PHIO has a market cap or net worth of $12.20 million. The enterprise value is -$4.60 million.
| Market Cap | 12.20M |
| Enterprise Value | -4.60M |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PHIO has 11.62 million shares outstanding. The number of shares has increased by 349.70% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +349.70% |
| Shares Change (QoQ) | +24.13% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 10.82% |
| Float | 11.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.32
| Current Ratio | 18.32 |
| Quick Ratio | 17.93 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.36% and return on invested capital (ROIC) is -50.27%.
| Return on Equity (ROE) | -76.36% |
| Return on Assets (ROA) | -46.65% |
| Return on Invested Capital (ROIC) | -50.27% |
| Return on Capital Employed (ROCE) | -69.95% |
| Weighted Average Cost of Capital (WACC) | 8.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.82M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.64% in the last 52 weeks. The beta is 0.81, so PHIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -53.64% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 43.55 |
| Average Volume (20 Days) | 161,076 |
Short Selling Information
The latest short interest is 313,798, so 2.70% of the outstanding shares have been sold short.
| Short Interest | 313,798 |
| Short Previous Month | 331,567 |
| Short % of Shares Out | 2.70% |
| Short % of Float | 2.72% |
| Short Ratio (days to cover) | 2.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | -6.53M |
| Operating Income | -11.52M |
| Pretax Income | -10.93M |
| Net Income | -10.93M |
| EBITDA | -11.51M |
| EBIT | -11.52M |
| Earnings Per Share (EPS) | -$1.40 |
Balance Sheet
The company has $17.03 million in cash and n/a in debt, with a net cash position of $17.03 million or $1.47 per share.
| Cash & Cash Equivalents | 17.03M |
| Total Debt | n/a |
| Net Cash | 17.03M |
| Net Cash Per Share | $1.47 |
| Equity (Book Value) | 16.46M |
| Book Value Per Share | 1.42 |
| Working Capital | 16.45M |
Cash Flow
In the last 12 months, operating cash flow was -$10.71 million and capital expenditures -$10,000, giving a free cash flow of -$10.72 million.
| Operating Cash Flow | -10.71M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 3,500 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.72M |
| FCF Per Share | -$0.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -349.70% |
| Shareholder Yield | -349.70% |
| Earnings Yield | -87.95% |
| FCF Yield | -86.22% |
Analyst Forecast
The average price target for PHIO is $14.00, which is 1,233.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 1,233.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jul 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |